Related references
Note: Only part of the references are listed.Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation
Haibo Wu et al.
NATURE COMMUNICATIONS (2022)
Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19
Avraham Unterman et al.
NATURE COMMUNICATIONS (2022)
Increased Expression of Tim-3 Is Associated With Depletion of NKT Cells In SARS-CoV-2 Infection
Jingzhi Yang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection
Claudia Ravaglia et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Unique immunological profile in patients with COVID-19
Stefania Varchetta et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
TIM-3 as a potential exhaustion marker in CD4+ T cells of COVID-19 patients
Zahra Modabber et al.
IMMUNITY INFLAMMATION AND DISEASE (2021)
Compartmental immunophenotyping in COVID-19 ARDS: A case series
Andreas Ronit et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Elevated plasma sTIM-3 levels in patients with severe COVID-19
Thor Ueland et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19
Min-Seok Rha et al.
IMMUNITY (2021)
Immune-checkpoint inhibitors from cancer to COVID-19: A promising avenue for the treatment of patients with COVID-19 (Review)
Silvia Vivarelli et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2021)
Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection
Jacob K. Files et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
B cell analysis in SARS-CoV-2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID-19
Nils H. Wildner et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2021)
Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8(+) T cells
Anthony Kusnadi et al.
SCIENCE IMMUNOLOGY (2021)
Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression
Andre F. Rendeiro et al.
LIFE SCIENCE ALLIANCE (2021)
Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19
Can Liu et al.
CELL (2021)
Galectin-9 as a biomarker of disease severity
Preeti Moar et al.
CELLULAR IMMUNOLOGY (2021)
SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry
Rose K. C. Moritz et al.
EUROPEAN JOURNAL OF CANCER (2021)
Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression
Ata Mahmoodpoor et al.
MOLECULAR IMMUNOLOGY (2021)
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses
Agnes Bonifacius et al.
IMMUNITY (2021)
The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression
Wei Huang et al.
JOURNAL OF IMMUNOLOGY (2021)
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Deborah Blythe Doroshow et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19
Jingyi Yang et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2021)
VISTA: A Target to Manage the Innate Cytokine Storm
Mohamed A. ElTanbouly et al.
FRONTIERS IN IMMUNOLOGY (2021)
Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection
Narjes Saheb Sharif-Askari et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
Enrichment of CCR6+CD8+ T cells and CCL20 in the lungs of mechanically ventilated patients with COVID-19
Anno Saris et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Severe Adaptive Immune Suppression May Be Why Patients With Severe COVID-19 Cannot Be Discharged From the ICU Even After Negative Viral Tests
Yue Zhou et al.
FRONTIERS IN IMMUNOLOGY (2021)
High Levels of the Cleaved Form of Galectin-9 and Osteopontin in the Plasma Are Associated with Inflammatory Markers That Reflect the Severity of COVID-19 Pneumonia
Gaowa Bai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Assessment of Galectin-1, Galectin-3, and Prostaglandin E2 Levels in Patients with COVID-19
Sumeyye Kazancioglu et al.
JAPANESE JOURNAL OF INFECTIOUS DISEASES (2021)
NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19
Laura Bergantini et al.
CELLS (2021)
TIM-3 in Leukemia; Immune Response and Beyond
Mahnaz Rezaei et al.
FRONTIERS IN ONCOLOGY (2021)
Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients
Mehdi Shahbazi et al.
MICROBIAL PATHOGENESIS (2021)
The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime
Marco Chilosi et al.
MODERN PATHOLOGY (2021)
Single-cell multi-omics analysis of the immune response in COVID-19
Emily Stephenson et al.
NATURE MEDICINE (2021)
Risk of COVID-19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors
Nikolai Klebanov et al.
ONCOLOGIST (2021)
Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment
Jia Liu et al.
mBio (2021)
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
Najmeh Bozorgmehr et al.
MBIO (2021)
Human Herpesvirus and the Immune Checkpoint PD-1/PD-L1 Pathway: Disorders and Strategies for Survival
Takayuki Murata
MICROORGANISMS (2021)
Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection
Hongyan Hou et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19
Aaron J. Wilk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated
Shima Shahbaz et al.
JOURNAL OF IMMUNOLOGY (2021)
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection
Martina Severa et al.
PLOS PATHOGENS (2021)
Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype
Amelia C. Trombetta et al.
FRONTIERS IN IMMUNOLOGY (2021)
Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19
Po-Ku Chen et al.
FRONTIERS IN IMMUNOLOGY (2021)
Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers
Vito Amodio et al.
CANCERS (2021)
BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer
Clemence Demerle et al.
FRONTIERS IN ONCOLOGY (2021)
HMGB1-TIM3-HO1: A New Pathway of Inflammation in Skin of SARS-CoV-2 Patients? A Retrospective Pilot Study
Gerardo Cazzato et al.
BIOMOLECULES (2021)
Extracellular and nuclear PD-L1 in modulating cancer immunotherapy
Wenjun Xiong et al.
TRENDS IN CANCER (2021)
A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis
Katie-May McLaughlin et al.
CURRENT ISSUES IN MOLECULAR BIOLOGY (2021)
NK cell receptor and ligand composition influences the clearance of SARS-CoV-2
Wan-Chen Hsieh et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the Literature
Laura Pala et al.
CANCER INVESTIGATION (2021)
Increasing Tim-3+CD244+, Tim-3+CD57+, and Tim-3+PD-1+T cells in patients with acute myeloid leukemia
Jiaxiong Tan et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2020)
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Meijuan Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
Hong-Yi Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
NKG2A and COVID-19: another brick in the wall
Luca Antonioli et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells
Yueping Liu et al.
CLINICAL INFECTIOUS DISEASES (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Mechanisms of HBV immune evasion
Adrian Kuipery et al.
ANTIVIRAL RESEARCH (2020)
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients
Silvia Bellesi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease
Christoph Schultheiss et al.
IMMUNITY (2020)
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine et al.
CELL (2020)
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Aaron J. Wilk et al.
NATURE MEDICINE (2020)
Tislelizumab: an investigational anti-PD-1 antibody for the treatment of advanced non-small cell lung cancer (NSCLC)
Si-Yang Liu et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Immunological and inflammatory profiles in mild and severe cases of COVID-19
Jin-Wen Song et al.
NATURE COMMUNICATIONS (2020)
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
Sara De Biasi et al.
NATURE COMMUNICATIONS (2020)
A Granulocytic Signature Identifies COVID-19 and Its Severity
Joana Vitte et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Impaired Cytotoxic CD8(+) T Cell Response in Elderly COVID-19 Patients
Jaana Westmeier et al.
MBIO (2020)
Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to AcutePlasmodium falciparumMalaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease
Marissa Herrmann et al.
FRONTIERS IN IMMUNOLOGY (2020)
Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils' but Impaired Monocytes' and Dendritic Cells' Responsiveness
Zuzana Parackova et al.
CELLS (2020)
Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset
Juan Francisco Gutierrez-Bautista et al.
FRONTIERS IN IMMUNOLOGY (2020)
Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19
Lin Yan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Storm of soluble immune checkpoints associated with disease severity of COVID-19
Yaxian Kong et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Increased PD-1+Tim-3+exhausted T cells in bone marrow may influence the clinical outcome of patients with AML
Jiaxiong Tan et al.
BIOMARKER RESEARCH (2020)
Is CD47 an innate immune checkpoint for tumor evasion?
Xiaojuan Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Unifying mechanism for different fibrotic diseases
Gerlinde Wernig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Higher PD-1 expression concurrent with exhausted CD8+T cells in patients with de novo acute myeloid leukemia
Jiaxiong Tan et al.
CHINESE JOURNAL OF CANCER RESEARCH (2017)
Molecular signature of CD8+ T cell exhaustion during chronic viral infection
E. John Wherry et al.
IMMUNITY (2007)